Prosecution Insights
Last updated: October 04, 2026
Application No. 18/471,763

PHARMACEUTICAL CONTAINER

Final Rejection §102§103
Filed
Sep 21, 2023
Priority
Mar 25, 2021 — EU 21164787.0 +6 more
Examiner
MIGGINS, MICHAEL C
Art Unit
1782
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Schott Pharma AG & Co. Kgaa
OA Round
2 (Final)
81%
Grant Probability
Favorable
3-4
OA Rounds
0m
Est. Remaining
97%
With Interview

Examiner Intelligence

Grants 81% — above average
81%
Career Allowance Rate
834 granted / 1032 resolved
+15.8% vs TC avg
Strong +17% interview lift
Without
With
+16.6%
Interview Lift
resolved cases with interview
Typical timeline
2y 5m
Avg Prosecution
53 currently pending
Career history
1073
Total Applications
across all art units

Statute-Specific Performance

§101
1.1%
-38.9% vs TC avg
§103
44.5%
+4.5% vs TC avg
§102
23.2%
-16.8% vs TC avg
§112
14.0%
-26.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1032 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . REJECTIONS WITHDRAWN There are no rejections withdrawn. REJECTIONS REPEATED The 102 and 103 rejections set forth in the non-final rejection of 3/6/26, pages 2-6, paragraphs 2-6. NEW REJECTIONS There are no new rejections. ANSWERS TO APPLICANT’S ARGUMENTS Applicant’s arguments of 6/8/26 have been carefully considered but are deemed unpersuasive. Applicant argues, “The Office acknowledges that neither Bicker nor Walther discloses various recited properties of the coated inner surface of the container. However, the Office contends, ‘said properties are inherent in Bicker and Walther since both references disclose the coating is made via PICVD with HDMSO as the precursor (see above) which is the same method used by applicant.’ (emphasis added). Applicant respectfully disagrees and submits the following remarks to show that Applicant's disclosed method is not disclosed, taught, or otherwise suggested by Bicker or Walther. In particular, the present application discloses in paragraph [00156] and [00158] that the method used to prepare containers according to the present invention includes a washing pretreatment of the container as well as plasma pretreatment with oxygen prior to the coating process. See also, paragraph [00159]. The pretreatment processes performed according to the present application will affect the surface characteristics of the container surface on which the coating is posited, which will also affect the properties of the formed coating. Bicker and Walther both fail to disclose, teach, or otherwise suggest these pretreatment processes in combination with the coating process parameters taught by the present application. Therefore, applicant submits that the Office has failed to properly establish that one skilled in the art would reasonably believe that the coatings of Walther and Bicker would inherently have the properties of independent claim 1, and all claims depending therefrom.” However, the instant specification discloses that there is no pretreatment process for containers that are made from polymers (see instant specification, paragraph [00127-00129]) so the pretreatment process is not necessary for the prior art to inherently disclose applicant’s recited lipid factor 1 or haze value. The instant specification also discloses that pretreatment applies to only some embodiments (see instant specification, paragraph [0038]). Furthermore, Bicker discloses either glass or polymer containers (paragraph [0025]). Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to MICHAEL C MIGGINS whose telephone number is (571)272-1494. The examiner can normally be reached Monday-Friday, 1-9 pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Aaron Austin can be reached at 571-272-8935. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MICHAEL C MIGGINS/Primary Examiner, Art Unit 1782 MCM August 9, 2026
Read full office action

Prosecution Timeline

Sep 21, 2023
Application Filed
Mar 06, 2026
Non-Final Rejection mailed — §102, §103
Jun 08, 2026
Response Filed
Aug 12, 2026
Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12746743
Multilayer Biodegradable Tube Laminate with Paper Layer and Protective Coating Arranged Thereon, Tube Body, and Tube
2y 8m to grant Granted Sep 29, 2026
Patent 12741452
HEAT AND SHOCK RESISTANT TRANSPARENT MEMBRANE
3y 6m to grant Granted Sep 22, 2026
Patent 12721931
FLEXIBLE TUBE FOR ENDOSCOPE, ENDOSCOPIC MEDICAL DEVICE, AND METHODS FOR PRODUCING THE SAME
3y 8m to grant Granted Sep 01, 2026
Patent 12722364
Article
3y 3m to grant Granted Sep 01, 2026
Patent 12725763
CERAMIC SINTERED BODY FOR SEMICONDUCTOR PRODUCTION EQUIPMENT AND MANUFACTURING METHOD THEREOF
2y 8m to grant Granted Sep 01, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
81%
Grant Probability
97%
With Interview (+16.6%)
2y 5m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 1032 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month